11 items found in 2 pages
Positive Impact:  A new generation of business with society at heart
This episode we explore Positive Impact. UCLB is helping to create a new generation of businesses from UCL academics specifically with positive societal impact at their heart. The commercialisation process can be a long road requiring financial, legal, and practical support. Nigel Campbell meets two inventors, Buffy Price Co-founder and COO of Carbon Re, an AI and Climate Tech company spinout from UCL and Cambridge, and Professor Pete Coffey from UCL Institute of Ophthalmology and Founder of Tenpoint Therapeutics; both who are on that journey on how their inventions might improve our future world. We also talk to Dr Anne Lane, CEO of UCLB to find out how UCLB finds the bright ideas which will improve lives, and what it takes to scale to a point where they are having true impact.
7
2/9/2024
Episode 11: The financial synergy between research commercialisation and the university
In this episode, Katy Bruce, CFO of UCL Business, and Charu Gorasia, CFO of UCL, will discuss the mutually beneficial relationship between the technology transfer office, such as UCLB, and the university. They will dive into the research income financial cycle and how the commercialisation income is distributed back into the research ecosystem. This podcast will also cover the challenges around commercialisation income, how to tackle these and what does the future hold
5
11/17/2023
Commercialising Research - the collaboration between tech transfer and investment
In the tenth episode, Dr Anne Lane, CEO of UCLB and Dr Chris Hollowood, CEO of Syncona Investment Management, discussed the collaboration between their respective organisations in commercialising research. Syncona is a leading healthcare investment company focused on creating, building and scaling a portfolio of global leaders in life science; and Chris has been instrumental in the foundation and the development of its gene therapy strategy. In this podcast, Anne and Chris discussed how Syncona came about, its close relationship with UCL and UCL Business, and what attracted Syncona to invest in four UCLB companies. Chris also discussed the tech transfer ecosystem and what is next for Syncona.
6
10/17/2023
HeLP-Diabetes: From early-stage social venture to national roll-out
In the ninth episode of this podcast series, Ana Lemmo Charnalia, Senior Business Manager at UCLB, is in conversation with Orla O’Donnell , Divisional Manager at the UCL Div of Biosciences and former Chief Operating Officer of Health Digital CIC, a Community Interest Company incorporated in 2015 to commercialise HeLP-Diabetes. It is also an opportunity to celebrate Professor Elizabeth Murray’s life, who led the development of HeLP-Diabetes. Join them in this discussion about their experiences and learnings from an early-stage social venture to the national roll-out of an online programme for people with Type 2 diabetes.
1
9/14/2023
UCL research offering new hope for people with difficult-to-treat cancers
Ground-breaking research from UCL could mean new treatments for patients with cancers that have not responded to standard therapies. The new therapies have evolved from research conducted by Dr Martin Pule and his team at the UCL Cancer Institute and NIHR University College London Hospitals Biomedical Research Centre. The research was commercialised into a spinout company called Autolus in 2014. The spinout process was supported by UCL Business Ltd (UCLB), UCL's commercialisation company. The company raised £30 million in investment from venture capital firm Syncona Partners. At the time this was one of the largest ever 'Series A' financing round for a European biotechnology company. That was followed by 'Series B' funding of £40 million and 'Series C' funding of £59 million, before an IPO in 2018. Find out how UCL spinouts solve complex global challenges and stimulate economic growth: https://ucl.ac.uk/enterprise Find out more about UCLB: https://www.uclb.com
70
9/11/2023
UCLB Episode 8:  Senceive Ltd: An organic growth success story
Over a 15 year journey, UCLB spinout company Senceive Ltd became the world leader in the design, manufacture and supply of wireless enabled remote condition monitoring solutions for use in rail and construction applications. Recognition of the innovative and scalable nature of Senceive’s solutions to keep people and critical infrastructure safe, led to the company being acquired by Eddyfi in April 2021. In this podcast, Senceive’s now retired CEO Graham Smith and Dr Steven Schooling from UCLB discuss their experiences and learnings as they turned an early-stage university spinout into a highly successful and profitable commercial enterprise, which at exit generated strong returns for all shareholders
6
8/22/2023
UCLB - Big Talks on Big Impacts
From chronic diseases, the climate crisis, to social injustice, how are we tackling the biggest problems of the 21st century? As UCLB celebrates its 30th anniversary in 2023, this new monthly podcast series will explore how we have supported UCL academics to create impact across several areas, such as: medical research, patient healthcare, the environment, and our wellbeing in a contemporary society. New episodes will be released every third Thursday of each month. Soundtrack by Harry Penfold and Thomas Shearwood.
5
6/13/2023
Evolving AI solutions in business
In the fifth episode of this podcast series, Marina Santilli, UCLB Associate Director, Engineering & Physical Sciences is in conversation with Dr. Daniel Hulme, CEO and Founder of Satalia. Satalia was UCL’s very first AI spinout company which is now part of the WPP Group of global companies. Daniel and Marina discuss how AI can help businesses make better and faster operational decisions by leveraging data, optimisation algorithms and machine learning techniques leading to significant savings and additional revenue. Daniel also discusses a holistic approach to a digital workforce and the future of AI in the light of recent progress in the field of generative AI
9
5/17/2023
12 >